Plasma p-tau181, Aβ1-42, and GFAP across Alzheimer's disease, mixed-type Alzheimer's disease, mild cognitive impairment, anxiety disorders, and depressive disorders.
- DOI
- 10.1016/j.brainres.2026.150606
- Published
- 2026 Oct 23
- Container
- Brain research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.brainres.2026.150606,
title = {Plasma p-tau181, Aβ1-42, and GFAP across Alzheimer's disease, mixed-type Alzheimer's disease, mild cognitive impairment, anxiety disorders, and depressive disorders.},
author = {Lou H and Huang C and Shen J and Wang D},
year = {2026},
journal = {Brain research},
doi = {10.1016/j.brainres.2026.150606},
url = {https://doi.org/10.1016/j.brainres.2026.150606}
}RIS
TY - JOUR TI - Plasma p-tau181, Aβ1-42, and GFAP across Alzheimer's disease, mixed-type Alzheimer's disease, mild cognitive impairment, anxiety disorders, and depressive disorders. AU - Lou H AU - Huang C AU - Shen J AU - Wang D PY - 2026 JO - Brain research DO - 10.1016/j.brainres.2026.150606 UR - https://doi.org/10.1016/j.brainres.2026.150606 ER -
APA
H, L., C, H., J, S., & D, W. (2026). Plasma p-tau181, Aβ1-42, and GFAP across Alzheimer's disease, mixed-type Alzheimer's disease, mild cognitive impairment, anxiety disorders, and depressive disorders.. Brain research. https://doi.org/10.1016/j.brainres.2026.150606
Source records
- pubmed · retrieved 2026-11-10T10:34:42.125Z